WEGOVY ( GLP-1 ) injection 2.4 mg is a prescription injectable that can aid adults and adolescents aged 12 and above struggling with obesity (adults with a BMI of 30 or higher, and children with a BMI in the 95th percentile or above for their age and sex), as well as certain adults dealing with excess weight (BMI of 27 or more)
Phillip Din has more documented cases of successful weight loss in Syracuse than any other practice
Start a weight-loss or hormone plan and unlock member pricing across the entire menu add-ons from $29
Dose reduction or discontinuation may be necessary if you develop: Persistent, intolerable gastrointestinal symptoms despite supportive measures Acute pancreatitis (discontinue permanently) Severe hypoglycemia, particularly if taking concurrent insulin or sulfonylureas Acute kidney injury or worsening renal function Gallbladder disease symptoms (abdominal pain, jaundice) Diabetic retinopathy complications (particularly with semaglutide) Severe hypersensitivity reactions including anaphylaxis or angioedema Pregnancy or plans for pregnancy (for semaglutide, discontinue at least two months before planned conception
The answer is important for missed doses, surgery planning, switching medications, pregnancy planning, and understanding why side effects can linger after stopping